Type I interferon signature associates with lung disease, drug‐associated immune reactions, and genetic variation in interferon‐linked pathways in Still's disease

Objectives To evaluate the relationship between type I interferon (IFN‐I) stimulated gene (ISG) expression, Still's disease, and the development of lung disease (LD) and drug‐associated immune reactions (DAIR) to IL‐1/IL‐6 inhibitors. Methods Whole blood ISG expression was quant…

Criar conta gratuita para acessar o conteúdo completo